Susquehanna International Group
SANA icon

Susquehanna International Group’s Sana Biotechnology SANA Stock Holding History

Susquehanna International Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
384,083
-37,472
-9% -$121K ﹤0.01% 7450
2026
Q1 		$1.21M Sell
421,555
-138,195
-25% -$544K ﹤0.01% 7391
2025
Q4 		$2.28M Buy
559,750
+46,229
+9% +$207K ﹤0.01% 5371
2025
Q3 		$1.82M Buy
513,521
+261,773
+104% +$946K ﹤0.01% 5986
2025
Q2 		$687K Sell
251,748
-65,571
-21% -$135K ﹤0.01% 8407
2025
Q1 		$533K Buy
317,319
+221,643
+232% +$620K ﹤0.01% 8765
2024
Q4 		$156K Buy
95,676
+28,112
+42% +$83.8K ﹤0.01% 10980
2024
Q3 		$281K Buy
67,564
+35,025
+108% +$184K ﹤0.01% 9743
2024
Q2 		$178K Sell
32,539
-26,858
-45% -$214K ﹤0.01% 10516
2024
Q1 		$594K Sell
59,397
-17,919
-23% -$134K ﹤0.01% 8089
2023
Q4 		$315K Sell
77,316
-173,962
-69% -$641K ﹤0.01% 9731
2023
Q3 		$972K Buy
251,278
+17,687
+8% +$95.1K ﹤0.01% 6686
2023
Q2 		$1.39M Sell
233,591
-166,499
-42% -$960K ﹤0.01% 5930
2023
Q1 		$1.31M Buy
400,090
+343,535
+607% +$1.37M ﹤0.01% 6135
2022
Q4 		$223K Sell
56,555
-124,845
-69% -$611K ﹤0.01% 9847
2022
Q3 		$1.09M Buy
181,400
+126,200
+229% +$911K ﹤0.01% 6422
2022
Q2 		$355K Sell
55,200
-74,760
-58% -$476K ﹤0.01% 9099
2022
Q1 		$1.07M Buy
129,960
+50,193
+63% +$406K ﹤0.01% 6935
2021
Q4 		$1.24M Buy
79,767
+27,739
+53% +$535K ﹤0.01% 6713
2021
Q3 		$1.17M Buy
52,028
+4,526
+10% +$95K ﹤0.01% 7151
2021
Q2 		$934K Buy
+47,502
New +$1.08M ﹤0.01% 7959

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Susquehanna International Group's SANA Position: Q2 2026 in Review

Susquehanna International Group reduced its Sana Biotechnology (SANA) stake by 8.9% in Q2 2026, selling an estimated $121K and leaving 384,083 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #7450.

Susquehanna International Group first reported a position in SANA in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.28M in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Susquehanna International Group held 384,083 shares of Sana Biotechnology worth $1.34M as of Q2 2026.
  • Susquehanna International Group sold 37,472 Sana Biotechnology shares in Q2 2026, an estimated $121K.
  • Sana Biotechnology made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #7450 holding.
  • Susquehanna International Group first reported a position in Sana Biotechnology in Q2 2021 and has held it in 21 quarters since.
  • Susquehanna International Group's Sana Biotechnology position peaked at $2.28M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.